186 related articles for article (PubMed ID: 37445668)
41. B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsets.
Becerra E; De La Torre I; Leandro MJ; Cambridge G
Clin Exp Immunol; 2017 Dec; 190(3):372-383. PubMed ID: 28800164
[TBL] [Abstract][Full Text] [Related]
42. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency.
Barbosa RR; Silva SL; Silva SP; Melo AC; Pereira-Santos MC; Barata JT; Hammarström L; Cascalho M; Sousa AE
J Clin Immunol; 2014 Jul; 34(5):573-83. PubMed ID: 24809296
[TBL] [Abstract][Full Text] [Related]
43. The Correlation Between Non-Hodgkin Lymphoma and Expression Levels of B-Cell Activating Factor and Its Receptors.
Shen X; Wang M; Guo Y; Ju S
Adv Clin Exp Med; 2016; 25(5):837-844. PubMed ID: 28028945
[TBL] [Abstract][Full Text] [Related]
44. BAFF system expression in double negative 2, activated naïve and activated memory B cells in systemic lupus erythematosus.
Álvarez Gómez JA; Salazar-Camarena DC; Román-Fernández IV; Ortiz-Lazareno PC; Cruz A; Muñoz-Valle JF; Marín-Rosales M; Espinoza-García N; Sagrero-Fabela N; Palafox-Sánchez CA
Front Immunol; 2023; 14():1235937. PubMed ID: 37675114
[TBL] [Abstract][Full Text] [Related]
45. Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation.
Kim J; Gross JA; Dillon SR; Min JK; Elkon KB
Autoimmunity; 2011 Mar; 44(2):69-81. PubMed ID: 21250838
[TBL] [Abstract][Full Text] [Related]
46. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.
Arkatkar T; Jacobs HM; Du SW; Li QZ; Hudkins KL; Alpers CE; Rawlings DJ; Jackson SW
Kidney Int; 2018 Oct; 94(4):728-740. PubMed ID: 29907458
[TBL] [Abstract][Full Text] [Related]
47. Regulatory roles of the tumor necrosis factor receptor BCMA.
Coquery CM; Erickson LD
Crit Rev Immunol; 2012; 32(4):287-305. PubMed ID: 23237506
[TBL] [Abstract][Full Text] [Related]
48. Expression of TNF-α, APRIL and BCMA in Behcet's disease.
Shaker OG; Tawfic SO; El-Tawdy AM; El-Komy MH; El Menyawi M; Heikal AA
J Immunol Res; 2014; 2014():380405. PubMed ID: 25759827
[TBL] [Abstract][Full Text] [Related]
49. Primary Cytomegalovirus Infection Significantly Impacts Circulating T Cells in Kidney Transplant Recipients.
Meijers RW; Litjens NH; Hesselink DA; Langerak AW; Baan CC; Betjes MG
Am J Transplant; 2015 Dec; 15(12):3143-56. PubMed ID: 26211927
[TBL] [Abstract][Full Text] [Related]
50. Identification of proteoglycans as the APRIL-specific binding partners.
Ingold K; Zumsteg A; Tardivel A; Huard B; Steiner QG; Cachero TG; Qiang F; Gorelik L; Kalled SL; Acha-Orbea H; Rennert PD; Tschopp J; Schneider P
J Exp Med; 2005 May; 201(9):1375-83. PubMed ID: 15851487
[TBL] [Abstract][Full Text] [Related]
51. Identification of new splice variants of the genes BAFF and BCMA.
Smirnova AS; Andrade-Oliveira V; Gerbase-DeLima M
Mol Immunol; 2008 Feb; 45(4):1179-83. PubMed ID: 17825416
[TBL] [Abstract][Full Text] [Related]
52. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone.
Moreaux J; Legouffe E; Jourdan E; Quittet P; Rème T; Lugagne C; Moine P; Rossi JF; Klein B; Tarte K
Blood; 2004 Apr; 103(8):3148-57. PubMed ID: 15070697
[TBL] [Abstract][Full Text] [Related]
53. B-cell activating factor (BAFF) and its receptors' expression in pediatric nephrotic syndrome is associated with worse prognosis.
Forero-Delgadillo J; Ochoa V; Restrepo JM; Torres-Canchala L; Nieto-Aristizábal I; Ruiz-Ordoñez I; Sánchez A; Barrera MC; Jimenez CA; Tobón GJ
PLoS One; 2022; 17(11):e0277800. PubMed ID: 36399480
[TBL] [Abstract][Full Text] [Related]
54. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway.
Endo T; Nishio M; Enzler T; Cottam HB; Fukuda T; James DF; Karin M; Kipps TJ
Blood; 2007 Jan; 109(2):703-10. PubMed ID: 16973958
[TBL] [Abstract][Full Text] [Related]
55. B-cell activating factor receptor expression is associated with germinal center B-cell maintenance.
Carrillo-Ballesteros FJ; Oregon-Romero E; Franco-Topete RA; Govea-Camacho LH; Cruz A; Muñoz-Valle JF; Bustos-Rodríguez FJ; Pereira-Suárez AL; Palafox-Sánchez CA
Exp Ther Med; 2019 Mar; 17(3):2053-2060. PubMed ID: 30783477
[TBL] [Abstract][Full Text] [Related]
56. TACI and BAFF-R mediate isotype switching in B cells.
Castigli E; Wilson SA; Scott S; Dedeoglu F; Xu S; Lam KP; Bram RJ; Jabara H; Geha RS
J Exp Med; 2005 Jan; 201(1):35-9. PubMed ID: 15630136
[TBL] [Abstract][Full Text] [Related]
57. Impaired B cell receptor signaling is responsible for reduced TACI expression and function in X-linked immunodeficient mice.
Uslu K; Coleman AS; Allman WR; Katsenelson N; Bram RJ; Alugupalli KR; Akkoyunlu M
J Immunol; 2014 Apr; 192(8):3582-95. PubMed ID: 24646744
[TBL] [Abstract][Full Text] [Related]
58. BAFF, involved in B cell activation through the NF-κB pathway, is related to disease activity and bone destruction in rheumatoid arthritis.
Zhang LL; Xiao H; Zhang F; Wu YJ; Shu JL; Li Y; Tai Y; Xu SQ; Xu JH; Wei W
Acta Pharmacol Sin; 2021 Oct; 42(10):1665-1675. PubMed ID: 33483588
[TBL] [Abstract][Full Text] [Related]
59. APRIL is overexpressed in cancer: link with tumor progression.
Moreaux J; Veyrune JL; De Vos J; Klein B
BMC Cancer; 2009 Mar; 9():83. PubMed ID: 19291294
[TBL] [Abstract][Full Text] [Related]
60. Soluble B-Cell Maturation Antigen Mediates Tumor-Induced Immune Deficiency in Multiple Myeloma.
Sanchez E; Gillespie A; Tang G; Ferros M; Harutyunyan NM; Vardanyan S; Gottlieb J; Li M; Wang CS; Chen H; Berenson JR
Clin Cancer Res; 2016 Jul; 22(13):3383-97. PubMed ID: 26960399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
